These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26423681)

  • 21. Mitochondrial targeting of bilirubin regulatory enzymes: An adaptive response to oxidative stress.
    Muhsain SN; Lang MA; Abu-Bakar A
    Toxicol Appl Pharmacol; 2015 Jan; 282(1):77-89. PubMed ID: 25478736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5.
    Abu-Bakar A; Moore MR; Lang MA
    Biochem Pharmacol; 2005 Nov; 70(10):1527-35. PubMed ID: 16183037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cytochrome P450 2A5 in a glucose-6-phosphate dehydrogenase-deficient mouse model of oxidative stress.
    Nichols KD; Kirby GM
    Biochem Pharmacol; 2008 Mar; 75(5):1230-9. PubMed ID: 18068688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyp2a5 Promoter-based Gene Reporter Assay: A Novel Design of Cell-based Bioassay for Toxicity Prediction.
    Abu-Bakar A; Hu H; Lang MA
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():72-80. PubMed ID: 29788535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of different fatty acids on BRL3A rat liver cell damage.
    Yang W; Liu R; Xia C; Chen Y; Dong Z; Huang B; Li R; Li M; Xu C
    J Cell Physiol; 2020 Sep; 235(9):6246-6256. PubMed ID: 32012270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
    Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway.
    Lu Y; Zhang XH; Cederbaum AI
    Toxicol Sci; 2012 Aug; 128(2):427-38. PubMed ID: 22552773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inducible bilirubin oxidase: a novel function for the mouse cytochrome P450 2A5.
    Abu-Bakar A; Arthur DM; Aganovic S; Ng JC; Lang MA
    Toxicol Appl Pharmacol; 2011 Nov; 257(1):14-22. PubMed ID: 21871474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the Cyp2a5 gene involves an aryl hydrocarbon receptor-dependent pathway.
    Arpiainen S; Raffalli-Mathieu F; Lang MA; Pelkonen O; Hakkola J
    Mol Pharmacol; 2005 Apr; 67(4):1325-33. PubMed ID: 15657367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP2A5/CYP2A6 expression in mouse and human hepatocytes treated with various in vivo inducers.
    Donato MT; Viitala P; Rodriguez-Antona C; Lindfors A; Castell JV; Raunio H; Gómez-Lechón MJ; Pelkonen O
    Drug Metab Dispos; 2000 Nov; 28(11):1321-6. PubMed ID: 11038160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver.
    Poça KS; Parente TE; Chagas LF; Leal BS; Leal HS; Paumgartten FJ; De-Oliveira AC
    BMC Res Notes; 2017 Mar; 10(1):125. PubMed ID: 28298240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cAMP mediated upregulation of CYP2A5 in mouse hepatocytes.
    Viitala P; Posti K; Lindfors A; Pelkonen O; Raunio H
    Biochem Biophys Res Commun; 2001 Jan; 280(3):761-7. PubMed ID: 11162586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of cytochrome P450 2A5 activity by lipopolysaccharide: low-dose effects and non-monotonic dose-response relationship.
    De-Oliveira AC; Poça KS; Totino PR; Paumgartten FJ
    PLoS One; 2015; 10(1):e0117842. PubMed ID: 25635819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5.
    Chen X; Owoseni E; Salamat J; Cederbaum AI; Lu Y
    Arch Biochem Biophys; 2018 Nov; 657():65-73. PubMed ID: 30222954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
    Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
    Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Induction of cytochrome P450 2A5 in transplanted mouse hepatoma].
    Kulikova LN
    Biomed Khim; 2004; 50(3):260-8. PubMed ID: 15354536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of RNA-protein interactions of mouse liver cytochrome P4502A5 mRNA.
    Tilloy-Ellul A; Raffalli-Mathieu F; Lang MA
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):695-703. PubMed ID: 10215609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism.
    Chambel SS; Santos-Gonçalves A; Duarte TL
    Biomed Res Int; 2015; 2015():597134. PubMed ID: 26120584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethanol induction of CYP2A5: permissive role for CYP2E1.
    Lu Y; Zhuge J; Wu D; Cederbaum AI
    Drug Metab Dispos; 2011 Feb; 39(2):330-6. PubMed ID: 21051534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of long chain fatty acids on lipid and glucose metabolism in monolayer cultures of bovine hepatocytes.
    Mashek DG; Grummer RR
    J Dairy Sci; 2003 Jul; 86(7):2390-6. PubMed ID: 12906057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.